Generative AI has upended how we write things, or even if we write at all. Now a startup wants to be the main character in the next chapter of that story: AI that replaces the role of the publisher. Spines is a self-publishing platform that claims that — thanks to being powered by artificial intelligence — it can do all the work of a publisher, and do it faster and cheaper.
The federal government has proven that it can navigate the difficult process of identifying drugs for price negotiation, gathering and analyzing key information, and negotiating…
This randomized clinical trial compares patient accrual rate, treatment conversion rate, complete gross resection rate, and other feasibility outcomes of a minimally invasive surgical approach…
This study examines the characteristics of academic researchers who obtained US government–linked drug patents.
This book is a comprehensive reference book covering the fetal and neonatal aspects of immunology and infectious diseases from a global perspective.
The ACA, primary care spending, Trump health nominees, Medicare and Medicaid, looming tariffs, abortion access, HIV, and more.
Mehmet Oz, Trump’s pick for the Centers for Medicare and Medicaid Services, owns healthcare stocks, promotes Medicare Advantage and criticizes the ACA.
The importance of continuity of care Previous research suggests that survival of patients may be associated with hospital organisational culture.1 Organisational factors such as culture,…
This prespecified secondary analysis of the COLOFOL randomized clinical trial examines overall and colorectal cancer–specific mortality rates in patients with stage II or III colorectal…
UCB has announced the FDA’s approval of bimekizumab, also known as Bimzelx, for patients with moderate-to-severe HS.
ESPN and Dan Orlovsky stunned viewers this week as they debuted new technology to break down Bills star Josh Allen.
